《大行报告》美银证券下调呷哺呷哺(00520.HK)目标价至20.7元 评级「买入」
美银证券发表报告表示,呷哺呷哺(00520.HK)去年收入按年跌10%,股东应占纯利约180万元人民币,意味下半年收益按年升7%及纯利升107%,虽然下半年收益增长减慢,惟在成本节省下毛利率表现高於预期。
该行下调其2021至2022年度盈利预测3%及2%,以反映收益增长放慢的预期,目标价由22.1元降6%至20.7元;报告称,呷哺呷哺本年至今累跌11%,估值相当於今年预测市盈率27倍,较领先餐饮同业低水45%,以2021至2023年税後纯利年均复合增长预测30%计,估值不高,重申「买入」评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.